These findings highlight the distinct biological consequences of individual K-Ras G12 mutations in colonic tumorigenesis and underscore therapeutic relevance of allele-specific signaling dependencies, offering a foundation for the development of effective, allele-informed therapeutic strategies for K-Ras mutant cancers. This evidence concerns the gene KRAS and cancer.